<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/70190FBA-17F4-410B-99F0-8883DA732818"><gtr:id>70190FBA-17F4-410B-99F0-8883DA732818</gtr:id><gtr:name>Royal Victoria Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4"><gtr:id>CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4</gtr:id><gtr:name>Cedars-Sinai Medical Center</gtr:name><gtr:address><gtr:line1>8700 Beverley BI #8211</gtr:line1><gtr:postCode>90048</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6963EF01-5A9A-4742-AF43-77647EDE7C21"><gtr:id>6963EF01-5A9A-4742-AF43-77647EDE7C21</gtr:id><gtr:name>British Athletics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AA3C61EB-D679-4375-8BDF-2861A9F5CB8B"><gtr:id>AA3C61EB-D679-4375-8BDF-2861A9F5CB8B</gtr:id><gtr:name>Ohio State University</gtr:name><gtr:address><gtr:line1>Student Academic Services Building</gtr:line1><gtr:line2>281 W. Lane Ave.</gtr:line2><gtr:postCode>43210</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Clinical and Experimental Medicine</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/70190FBA-17F4-410B-99F0-8883DA732818"><gtr:id>70190FBA-17F4-410B-99F0-8883DA732818</gtr:id><gtr:name>Royal Victoria Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4"><gtr:id>CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4</gtr:id><gtr:name>Cedars-Sinai Medical Center</gtr:name><gtr:address><gtr:line1>8700 Beverley BI #8211</gtr:line1><gtr:postCode>90048</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6963EF01-5A9A-4742-AF43-77647EDE7C21"><gtr:id>6963EF01-5A9A-4742-AF43-77647EDE7C21</gtr:id><gtr:name>British Athletics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AA3C61EB-D679-4375-8BDF-2861A9F5CB8B"><gtr:id>AA3C61EB-D679-4375-8BDF-2861A9F5CB8B</gtr:id><gtr:name>Ohio State University</gtr:name><gtr:address><gtr:line1>Student Academic Services Building</gtr:line1><gtr:line2>281 W. Lane Ave.</gtr:line2><gtr:postCode>43210</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FB4660FA-B951-42E5-A0AE-F9093BB40CE4"><gtr:id>FB4660FA-B951-42E5-A0AE-F9093BB40CE4</gtr:id><gtr:firstName>Kristien</gtr:firstName><gtr:surname>Boelaert</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601811"><gtr:id>F5D91E5C-F23B-4541-82FB-4DF1EF3E425D</gtr:id><gtr:title>Novel pathways promoting thyroid tumourigenesis and growth</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601811</gtr:grantReference><gtr:abstractText>Thyroid cancers are the most common endocrine malignancies in England and Wales and their incidence is rising. Since these tumours have a tendency to recur following surgery, patients are often offered treatment with radioiodine (131I) to prevent tumour re-growth. In addition, benign thyroid gland enlargements (goitres) affect up to 50% of the population and 131I therapy is increasingly used in their management. 
Although we remain unsure which mechanisms control the growth of these thyroid tumours, our studies have shown that a cancer-causing gene called pituitary tumor transforming gene (PTTG) plays a role. PTTG stimulates tissue growth through interactions with growth promoting molecules and our preliminary findings demonstrate that PTTG directly affects the uptake of radioiodine by thyroid cells. We propose to assess the ways in which PTTG interacts with a number of growth factors and which mechanisms are involved in this process using thyroid cells in culture. Additionally we will study the in vivo effects of reduced and increased PTTG expression in the thyroid using mouse models. Finally we propose to investigate if the effects of PTTG on radioiodine uptake can be inhibited in order to improve the treatment of thyroid diseases. These investigations will be carried out by researchers who have made significant contributions to characterising the role of PTTG in thyroid disease.</gtr:abstractText><gtr:technicalSummary>Thyroid neoplasia (cancers) and hyperplasia (goitres) are common clinical entities and interactions between oncogenes and growth factors are pivotal in their pathogenesis. We have identified the pituitary tumor transforming gene (PTTG) as a novel molecular indicator of prognosis for thyroid cancers. PTTG has a dual role in thyroid tumourigenesis firstly by inducing genetic instability and subsequently by promoting tumour growth and angiogenesis. Interactions between PTTG and growth factors (e.g.FGF-2) are well described and we have demonstrated that this is regulated via PTTG?s SH3-interacting domain. Recently mitogenic factors implicated in thyroid tumourigenesis (IGF-1, TGF?, HGF and EGF) were found to regulate PTTG in breast cancer and astrocytoma cells. Of particular clinical relevance are our preliminary findings that PTTG and its binding factor (PBF) repress expression and function of the sodium iodide symporter (NIS) thereby potentially affecting the treatment of thyroid diseases with radioiodine. 
We hypothesise (i) that PTTG promotes the growth of thyroid tumours through paracrine/autocrine interactions with growth factors and (ii) that this is regulated via PTTG?s SH3-interacting domain. (iii) Additionally, we propose that PTTG under-and overexpression affects thyroid gland growth and (iv) that amelioration of PTTG-induced NIS repression may improve treatment of thyroid diseases with radioiodine. 
To test our first hypothesis we propose to use a number of in vitro techniques to unravel the autocrine/paracrine pathways of interaction between PTTG and growth factors such as IGF-1, EGF, HGF and TGF? in thyroid cells to identify potential therapeutic targets. Additionally we will relate the expression of these mitogens in our thyroid tissue cohort to our existing molecular and clinical findings to determine their role as prognostic markers. Secondly, we will explore the mechanism of growth factor-PTTG interaction using a mass spectrometry proteomics appr to identify functionally relevant proteins determining this interaction. Thirdly we will investigate the effects of PTTG under- and targeted overexpression on thyroid growth in mouse models. We will attempt to induce goitres in PTTG knockout mice (provided by Professor Melmed, University of California) and develop a thyroglobulin-driven PTTG transgenic mouse model in collaboration with Professor Fagin (University of Cincinnati). We will examine effects on thyroid specific gene expression and thyroid cell differentiation and function in both models. Finally we will investigate if amelioration of PTTG?s effects could lead to improvements in the treatment of patients with thyroid disease with radioiodine. We will investigate the effects of PTTG/PBF on subcellular localisation and function of NIS and determine if disruption of PTTG-induced NIS repression represents a potential means of modulating the treatment of thyroid diseases with radioiodine.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>663280</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Immunotherapy for Graves' disease</gtr:description><gtr:id>275BD601-A0BB-420B-BB95-C7D628730E1B</gtr:id><gtr:impact>First in man study about to commence. No outputs yet.</gtr:impact><gtr:outcomeId>56e05b137dce61.14130404-1</gtr:outcomeId><gtr:partnerContribution>Help with grant application. Identification of eligible patients. Planned treatment of patients.</gtr:partnerContribution><gtr:piContribution>Centre in a first in man study of immunotherapy in patients with Graves' disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>Novel genes in congenital hypothyroidism</gtr:description><gtr:id>03DBDB00-317A-454A-BA2E-BA83063F4EDF</gtr:id><gtr:impact>Award of UHB Charities grant for whole exome sequencing on 200 samples from consanguinous familes with congenital hypothyroidism.</gtr:impact><gtr:outcomeId>EGngRwBJ1Cd-1</gtr:outcomeId><gtr:piContribution>New Collaboration with Professor Eamonn Maher to fund project evaluating new candidate genes in congential hypothyroidism.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>Proteomics approach to investigate proteins interacting with PTTG</gtr:description><gtr:id>D18A046A-A570-4C7A-865B-FE5EB37173DD</gtr:id><gtr:impact>This collaboration has resulted in obtaining MRC funding for another Clinical Research Fellow and forms part of a University of Birmingham (College of Medical and dental Sciences)-funded PhD consortium.</gtr:impact><gtr:outcomeId>ktHUPf2suw4-1</gtr:outcomeId><gtr:piContribution>Collaboration with Dr Ashley Martin, School of Cancer Sciences, University of Birmingham. We are currently employing mass-spectrometry appraoches to investigate the proteins interacting with and binding to PTTG and PBF. Protocols for experiments have been optimised.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Genetic Medicine</gtr:department><gtr:description>Rituximab in young patients with Graves' disease</gtr:description><gtr:id>BCEFD987-CE88-4DF6-A6CC-F3A0A9736A5F</gtr:id><gtr:impact>Multidisciplinary collaboration between paeditricians, endocrinologists and genetecists</gtr:impact><gtr:outcomeId>5463914f091131.51065218-1</gtr:outcomeId><gtr:partnerContribution>Collaborative wirting of grant proposal which has passed the outline stage of MRC-DFPS scheme</gtr:partnerContribution><gtr:piContribution>Obtained funding from the MRC-DFPS scheme for phase II trial of Rituximab in young patient with Graves' disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>prevention of excessive weight gain following antithyroid treatment</gtr:description><gtr:id>19C9D132-76D2-4134-9351-80B39988E698</gtr:id><gtr:impact>Grant application to be submitted January-June 2014</gtr:impact><gtr:outcomeId>UrqXPx8enam-1</gtr:outcomeId><gtr:partnerContribution>Grant application to NIHR/RfPB planned</gtr:partnerContribution><gtr:piContribution>Development of interventional trial</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Ophthalmology</gtr:department><gtr:description>Set up of trial to evaluate Digital Infrared Thermal Imaging for Early Diagnosis and Disease Monitoring in Thyroid Eye Disease</gtr:description><gtr:id>21FA0389-14A8-4667-BA2F-8EAF056ED564</gtr:id><gtr:impact>Successful grant application</gtr:impact><gtr:outcomeId>T2ZAGw8ng7z-1</gtr:outcomeId><gtr:partnerContribution>Application of grant funding and set up of trail evaluating new technology</gtr:partnerContribution><gtr:piContribution>Application for grant funding and set up of trail evaluating this new technology</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cedars-Sinai Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Investigation of thyroid gland of PTTG knockout mice</gtr:description><gtr:id>5DCE8316-0DC2-4C68-9C22-16C82C28942E</gtr:id><gtr:impact>Long standing collaboration. Co-authors on PMID: 15591026. Experiments involving PTTG knockout mice are currently being set up. Results expected by middle of 2010.</gtr:impact><gtr:outcomeId>3AD5376F544-1</gtr:outcomeId><gtr:partnerContribution>Professor Melmed has supplied PTTG knockout mice for studies of goitrogenesis and thyroid tumour growth</gtr:partnerContribution><gtr:piContribution>Currently investigating thyroid status of PTTG knockout mice. Experiments of goitre induction to be set up in 2010.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Generation of transgenic mouse model</gtr:description><gtr:id>204D7FF0-E125-4A12-AFD1-4C4E66AF19F2</gtr:id><gtr:impact>Abstract regarding initial results from characterisation studies submitted to Annual Meeting of BES.</gtr:impact><gtr:outcomeId>6FEEF3DD131-1</gtr:outcomeId><gtr:partnerContribution>Generation of mouse model with targetted thyroid specific overexpression of PTTG.</gtr:partnerContribution><gtr:piContribution>Screening and characterisation of transgenic mouse model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harbor-UCLA Medical Center</gtr:department><gtr:description>Determination of mouse serum TSH concentrations</gtr:description><gtr:id>D905AA98-6989-4796-8CCF-A45AD466282C</gtr:id><gtr:impact>Data regarding mouse serum TSH concentrations are currently being incorporated into abstracts and manuscripts describing the mouse models.</gtr:impact><gtr:outcomeId>34C5CF44F85-1</gtr:outcomeId><gtr:partnerContribution>In collaboration with Dr Parlow we have been able to determine serum TSH concentrations for our 2 current transgenic mouse models of overexpression of PTTG and PBF respectively.</gtr:partnerContribution><gtr:piContribution>Generation of thyroid specific mouse model overexpressing PTTG in thyroid gland. Obtaining of mouse serum samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Radiology</gtr:department><gtr:description>Elastography in the diagnosis of thyroid cancer</gtr:description><gtr:id>EAFC73B5-360F-46B1-A532-292C366B7012</gtr:id><gtr:impact>HTA-preliminary application accepted. Working on full application</gtr:impact><gtr:outcomeId>RZSV1EUB8Rn-1</gtr:outcomeId><gtr:partnerContribution>Working towards submission of full application for HTA funded grant</gtr:partnerContribution><gtr:piContribution>Application for HTA-funded grant evaluating the usefullness of elastography in diagnosis of thyroid cancer</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Surrey</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Health and Medical Sciences</gtr:department><gtr:description>Iodine supplementation in pregnancy</gtr:description><gtr:id>B5E3FA8C-325A-4479-B6F5-87EF0A0E1996</gtr:id><gtr:impact>Successful submission of outline HTA application</gtr:impact><gtr:outcomeId>SuFyePoSDjf-1</gtr:outcomeId><gtr:partnerContribution>Submission of outline grant application to HTA with succesful outcome</gtr:partnerContribution><gtr:piContribution>Submission of outline grant application to HTA with succesful outcome</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Victoria Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Radiology</gtr:department><gtr:description>HTA elastography trial</gtr:description><gtr:id>09E4A932-53FB-4094-841C-C5C320AF94D4</gtr:id><gtr:impact>Successful grant application</gtr:impact><gtr:outcomeId>BpLDLomq5s5-2</gtr:outcomeId><gtr:partnerContribution>Successful HTA grant application</gtr:partnerContribution><gtr:piContribution>Successful HTA grant application</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>British Athletics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>British Athletics</gtr:description><gtr:id>E53BF30A-3D4D-4E08-A41E-765F110344F0</gtr:id><gtr:impact>Drafting of guidelines on management of hypothyroidism in athletes
Presented at British Association of Sports and Exercise Meeting</gtr:impact><gtr:outcomeId>5463905035f7d4.29278796-1</gtr:outcomeId><gtr:partnerContribution>Continued liaison and drafting of guidelines on management of hypothyroidism in athletes</gtr:partnerContribution><gtr:piContribution>Advice on management of hypothyroidism in athletes</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Investigation of autocrine and paracrine pathways of interaction between PTTG and growth factors</gtr:description><gtr:id>4B9D5EE2-4B1D-4201-A442-6A84076F9A7E</gtr:id><gtr:impact>Co-authors on numerous publications. PMID: 19706688, 17297475, 16926250, 16394085, 15886233, 15591026</gtr:impact><gtr:outcomeId>866C44419E9-1</gtr:outcomeId><gtr:partnerContribution>Training of staff in primary human and mouse thyroid culture techniques. Intellectual contribution and shared expertise.</gtr:partnerContribution><gtr:piContribution>Gained expertise in primary culture of mouse thyroid cells which is an important part of the characterisation of our transgenic mouse models. Continued valuable discussions regarding pathways involving growth factors and their role in thyroid tumourigenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ohio State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Investigation of management of medullary thyroid cancer in multi-centre collaboration</gtr:description><gtr:id>2D0266B8-5FCE-4DCA-A52E-0F4767A960BE</gtr:id><gtr:impact>Publications: PMID 27604949 and PMID 23757627</gtr:impact><gtr:outcomeId>58c9bd9aa330a1.35711894-1</gtr:outcomeId><gtr:partnerContribution>Provision of data, analysis of results, contribution to writing of manuscripts</gtr:partnerContribution><gtr:piContribution>Provision of data regarding diagnosis, management and outcomes of patients with medullary thyroid cancer.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Radiology</gtr:department><gtr:description>HTA elastography trial</gtr:description><gtr:id>90B7F024-C7F1-48F0-B9DF-43FAAD12397E</gtr:id><gtr:impact>Successful grant application</gtr:impact><gtr:outcomeId>BpLDLomq5s5-1</gtr:outcomeId><gtr:partnerContribution>Successful HTA grant application</gtr:partnerContribution><gtr:piContribution>Successful HTA grant application</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Institute of Oncology (IEO)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Analysis of data regarding mortality from hyperthyroidism</gtr:description><gtr:id>01741E73-2E03-43CC-B81B-D56209A227F5</gtr:id><gtr:impact>Abstract submitted to Annual Meeting of British Endocrine Societies. Masnuscript to be submitted to high impact journal early 2010</gtr:impact><gtr:outcomeId>8745A0BA666-1</gtr:outcomeId><gtr:partnerContribution>Collaboration with Dr Maisonneuve in the Unit of Clinical Epidemiology for analysis of large mortality study</gtr:partnerContribution><gtr:piContribution>Gathering of mortality data from large patient cohort with hyperthyroidism</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Outcomes relating to thyroid function testing</gtr:description><gtr:id>6DAF072F-61B5-4247-8BC2-AAC8B33566D6</gtr:id><gtr:impact>Abstract submission</gtr:impact><gtr:outcomeId>PeZ7HXPNaZS-1</gtr:outcomeId><gtr:partnerContribution>Set up of new study and submission of abstracts</gtr:partnerContribution><gtr:piContribution>Set up of new study and submission of abstracts</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BTF Patient Forum - Hyperthyroidism and Graves' Disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A6E19F06-F408-4092-BDD5-48306E540B9E</gtr:id><gtr:impact>Presentation to the GAH/BTF patient group with thyroid disorders sparking lively discussions</gtr:impact><gtr:outcomeId>56e076bac14dd6.86307510</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Induction of hypothyroidism with radioactive iodine therapy is associated with improved survival in patients with hyperthyroidism</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D6861B26-1A39-423F-94BF-2CDE3DAFEC00</gtr:id><gtr:impact>Talk was attended by over 500 health professionals with vivid discussion following the presentation.

We have engaged in lively scientific discussions with other researchers working in similar fields</gtr:impact><gtr:outcomeId>pW6jM2Rgzyg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Belgian Thyroid club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DDBE2762-4754-4982-B404-8D216BBB381C</gtr:id><gtr:impact>200 attendees attended key note lecture which sparked discussion afterwards

Increased international profile</gtr:impact><gtr:outcomeId>Lym2Nr58DBi</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Forum Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>55CF859E-86FE-4F90-A6F4-D443611A2DFC</gtr:id><gtr:impact>60 patients attended presentation

A number of patients asked to be referred to my clinic</gtr:impact><gtr:outcomeId>rEUR6F277ep</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Grand Round at the Mayo Clinic</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3768B52E-1A1E-4B85-AF31-C364E6C603E0</gtr:id><gtr:impact>50-60 Endocrinologists attended the grand round

Stimulated interesting discusssions with colleagues</gtr:impact><gtr:outcomeId>Wdjr9gSGyBt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C26EA796-9C53-43C9-860D-931A9EFE2199</gtr:id><gtr:impact>15 minute oral plenary abstract presented at the annual meeting of the American Thyroid Association. This was presented by Dr Vicki Smith

We have engaged in lively scientific discussions with other researchers working in similar fields.</gtr:impact><gtr:outcomeId>AB1736CDCAE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Trustee GetAhead Charity</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8A0C857E-D2F3-4056-B6EF-E7329D3A8263</gtr:id><gtr:impact>Decided on funding of research applications

Stimulating exciting research projects</gtr:impact><gtr:outcomeId>5463c5937f5703.14837777</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>97th Annual Meeting of the Endocrine Society (Endo 2015). Meet the Professor Session, San Diego, USA, March 2015. &quot;ESAP- Thyroid Cases&quot;</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>04375B7C-27D6-4CC3-9DE5-B4EBB911ABED</gtr:id><gtr:impact>Presented difficult cases of thyroid Cancer at the largest international Endocrine Meeting.</gtr:impact><gtr:outcomeId>56e0793ed76fe5.98173064</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Milton Keynes BTF meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D4B82307-621C-4400-9CC1-324C6BDF925E</gtr:id><gtr:impact>60 patients attended presentation and participated in lively discussion

Increased interaction with national patient group</gtr:impact><gtr:outcomeId>H9m3sqdnQbS</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Controversies and Innovations in the Assessment of Thyroid Nodules</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CB5A14D9-A028-4AF6-9F6F-331872947232</gtr:id><gtr:impact>150 people attended an animated workshop with vibrant discussions. Current controversies and guidance on diagnosis and management of thyroid nodules were discussed.</gtr:impact><gtr:outcomeId>58c9c157192299.08057927</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Radioiiodine Training Scheme</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8C61BB63-477D-4A8C-BC67-D5D2E43CF013</gtr:id><gtr:impact>30 particiapnts who are now trying to obtain license for administration of radioiodine

Applications for 131-I adminstration licenses ongoing</gtr:impact><gtr:outcomeId>dxgJJFTZ9y2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bart's and The London Endocrine Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3A14E376-499F-49F0-9F8B-42FA49C359F2</gtr:id><gtr:impact>60 clinicians and scientists attended the grand round which sparked stimulating discussions

New interactions with other Endocrinologists were established.</gtr:impact><gtr:outcomeId>peqFA6AiQaQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Thyroid cancer: causes, treatments, side effects and recurrence</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>37C8D42F-D81B-4C69-90DF-D615D1604DB3</gtr:id><gtr:impact>Presentation to 35 patients with thyroid cancer followed by a question and answer session.

The presentation was well received with positive patient comments quoted on the BTF website.</gtr:impact><gtr:outcomeId>KyC4udvnig9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ATA meet the professor</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3CCEA5B6-982B-4CD9-B9AD-BC5099E6BF70</gtr:id><gtr:impact>150 people attended talk which sparked questions and discussion.

Invited to give further talks in 2014</gtr:impact><gtr:outcomeId>dFAvRtqf1DH</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Academy of Medical Sciences Outreach and Mentoring Event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82562140-9166-4AD0-8871-6F244E23EA02</gtr:id><gtr:impact>Gave presentation on how to manage multiple roles in a Clinical Academic Career.

Stimulated interesting discussion and resulted in contact with several colleagues from across the university asking for advice when applying for fellowships.</gtr:impact><gtr:outcomeId>ijfqzEk9kvz</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SfE Clinical Update Course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8970D1F7-48EC-4FE3-B4A6-10C4629A988A</gtr:id><gtr:impact>Gave brief presentation and facilitated workshop

Improvement in part 3 exit exam results of participants</gtr:impact><gtr:outcomeId>CDfKAvVN3Wh</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Paucity of symptoms and signs of hyperthyroidism in elderly people</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CC2BD885-9628-42FC-9A3F-C86460EEADF4</gtr:id><gtr:impact>Presented findings of our epidemiology research into the management of thyroid disorders in general

This talk highlighted the need for physicians to adopt a low treshold to perform thyroid function testing in elderly people.</gtr:impact><gtr:outcomeId>51BE024AAE5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A novel mechanism of reduced iodide uptake in differentiated thyroid cancer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FA19BDD7-FF15-487D-80BF-0B4804628835</gtr:id><gtr:impact>Gave 25 minute presentation on research results to the Association of Physicians Annual Meeting in Birmingham, April 2009

This presentation highlighted our novel findings and ongoing research into the pathogenesis of thyroid tumour growth. This was a particularly esteemed audience.</gtr:impact><gtr:outcomeId>EF2E91273A6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Symposium Speaker European Congress for Endocrinology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F0ECDE16-5E65-40D3-B2FC-5953EBC7A334</gtr:id><gtr:impact>200 clinicians attended talk on &amp;quot;Thyroid Dysfunction in the Elderly&amp;quot;

Asked to write review article for Nature Reviews in Endocrinology.</gtr:impact><gtr:outcomeId>ooc48SpG3GF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3.	Christie Hospital Manchester Annual Educational meeting for Joint Endocrine Tumour Group. New UK thyroid cancer guidelines: highlights&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BE56EBB3-9021-4380-91EB-E775276555F4</gtr:id><gtr:impact>Presented main aspects of New UK Thyroid Cancer Guidelines which I co-wrote</gtr:impact><gtr:outcomeId>56e078b1653ab8.48122163</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Management of Hypothyroidism</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B058A06C-DD54-40FA-AAD4-82F2BB4B414C</gtr:id><gtr:impact>Presented update on management of hypothyroidism according to recent guidance

Gave presentation to ~ 200 nurses which stimulated interesting discussions</gtr:impact><gtr:outcomeId>qzeTVUvDmNT</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ATA symposium speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>357E231E-D724-4497-BA3E-EFDA92094E84</gtr:id><gtr:impact>Talk sparked questions and discussion afterwards

Invitations for further presentations</gtr:impact><gtr:outcomeId>5463d03d346841.23204612</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BACO presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5FC97B4D-254A-4A37-A9D9-77804141BD9C</gtr:id><gtr:impact>Gave presentation which sparked interesting discussions

Continued discussions with other helath professionals</gtr:impact><gtr:outcomeId>g2S7h8FyBfb</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Forum Discussion</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A5876A02-06CE-4E82-9D26-2DE7F982585E</gtr:id><gtr:impact>Thyroid Eye Disease Charitable Trust meeting attended by around 50 patients.

Stimulated engaging discussions with patients and colleagues</gtr:impact><gtr:outcomeId>EyUZaEEGo6F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BAETS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2AAE97BF-5E76-4BEF-902D-8D675DBEF1D4</gtr:id><gtr:impact>Presentation of new UK thyroid cancer guidelines

Further invitations to deliver talks on the same subject</gtr:impact><gtr:outcomeId>5463cf7745d506.63094459</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Role of new TKIs in thyroid cancer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AB53F4BF-2864-48DD-AD27-A863F8A8C90B</gtr:id><gtr:impact>Presented the most recent evidence on use of novel drugs used in the management of thyroid cancer in a PechaKucha format.</gtr:impact><gtr:outcomeId>58c9c20c96b2d6.71546831</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at local high school (KEHS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>78628DC0-3F89-4DBA-8B2B-6ACA5930BD6E</gtr:id><gtr:impact>Talked to girls at local high school about life as a clinical academic. 100 girls attended and a long discussion was held afterwards.

School asked me to return in 2014.</gtr:impact><gtr:outcomeId>iPuyBZy44xZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Marsden Conference: &quot;ATA vs ETA vs BTA thyroid cancer guidelines. Is there a consensus?&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6BBAEC4A-97A1-4631-A695-8CE2F8EB48EE</gtr:id><gtr:impact>Comparison of National, Europen and american Guideloines on the Management of Thyroid Cancer</gtr:impact><gtr:outcomeId>56e077e9e2f580.11421714</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>University of Birmingham, College of Medical and Dental Sciences, PhD consortium on Endocrine Cancer</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>University of Birmingham</gtr:fundingOrg><gtr:id>12E28D55-561F-403C-9182-976A6E9B1C28</gtr:id><gtr:outcomeId>KdDSMMLTnaH0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>649169</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J001414/1</gtr:fundingRef><gtr:id>13B92C1D-68C1-4A18-9263-B5221C8C7236</gtr:id><gtr:outcomeId>ZhyUXWqSGcH</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>82000</gtr:amountPounds><gtr:country>Thailand, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Siriraj Medical School PhD studentship</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Siriraj Medical School</gtr:fundingOrg><gtr:id>94523FA0-EDA7-4849-BBAA-7497C2BEB4DE</gtr:id><gtr:outcomeId>54638dc4da6210.66457336</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>76000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DTA PhD studentship</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E26123D6-CA95-44A7-A7BB-0C2C5834D405</gtr:id><gtr:outcomeId>AD6C09427530</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>976000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DPFS</gtr:description><gtr:end>2020-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8539B077-F1EE-4E8E-9E15-A8CD7B19CC1A</gtr:id><gtr:outcomeId>56e05c70a42520.95893523</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>313615</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9AF18A91-EF1D-4247-AA07-C19E8064F7A2</gtr:id><gtr:outcomeId>A711FB8D58C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>HTA project grant - commisioned call</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>12/19/04</gtr:fundingRef><gtr:id>9FD3E8C1-7FCF-4718-98B9-0680CDBD189D</gtr:id><gtr:outcomeId>MpT31MmZGmU</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Endocrinology Trust Quality Improvement Project</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Society for Endocrinology</gtr:fundingOrg><gtr:id>29DC5CB4-6D58-49B5-A7BE-B674966AC64B</gtr:id><gtr:outcomeId>546365adc86ed3.05320549</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34985</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UHB Charities Research Grant</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Queen Elizabeth Hospital Birmingham Charity (QEHB)</gtr:fundingOrg><gtr:id>DF11543B-4B64-4615-8209-6E9527012095</gtr:id><gtr:outcomeId>SiLz3AaPpEh0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small Grant Award Scheme</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Thyroid Eye Disease Charitable Trust (TEDct)</gtr:fundingOrg><gtr:id>165C7E0E-9151-4C13-9A31-63BA30A4AB5D</gtr:id><gtr:outcomeId>Fdogf8KY6Hj</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>825000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Large Project Grant</gtr:description><gtr:end>2020-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>24879277-A4CE-4ED3-B786-5790AC955F39</gtr:id><gtr:outcomeId>58c9bf55774250.61967788</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Thyroid Association Executive Committee member</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>878DAD3A-80E4-4618-996A-31C1C56FAFDF</gtr:id><gtr:impact>Improvements in the management of patients with thyroid disorders.</gtr:impact><gtr:outcomeId>aU67kWFEh66</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Course Organiser for National 131-I training scheme</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44712821-12B7-4719-8842-23773C58BC75</gtr:id><gtr:impact>An increased number of consultants applying for radioiodine licenses amongst endocrinologists.</gtr:impact><gtr:outcomeId>o5qRVGmHQqH</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Election to Diabetes and Endocrinology SCE Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4E7F204C-09DD-421A-817D-D1207A75793F</gtr:id><gtr:impact>Setting of questions for Diabetes and Endocrinology Exit exam</gtr:impact><gtr:outcomeId>g1uGUbbFzGC</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Election to American Endocrine Society Self-Assessment Committee</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>F2D37F6E-80EE-4DBD-8CC8-7FAB2A9A7017</gtr:id><gtr:impact>Member of panel setting question for professional licensing exam for US endocrinologists</gtr:impact><gtr:outcomeId>iAzKcoMqZZB</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Set-up of working group for national guidelines on management of thyroid disorders in pregnancy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CAFE1E9E-9E7E-444A-8E88-B257E74ABE21</gtr:id><gtr:outcomeId>56e07afb4ab3d8.49123407</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in UK Low Iodine Diet Working Party'</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B8672F21-1AEE-4E1A-AD3C-3CDE09C67958</gtr:id><gtr:outcomeId>56e07b6e6c3992.14663161</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SfE Clinical Update Course</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>E1947F67-3020-42E6-9CCF-B317209D3CFE</gtr:id><gtr:impact>Improved management of patients with thyroid nodules and thyroid cancer by educating clinicians in training</gtr:impact><gtr:outcomeId>koXh4sSrE86</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UK guidelines for management of thyroid disease in pregnancy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0A773479-EA15-4617-AC7D-4D8D0756C4FB</gtr:id><gtr:outcomeId>58c9c2d71c6e93.90703070</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Thyroid Cancer Development Group Guidelines</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>British Thyroid Association Guidelines for the Management of</gtr:guidelineTitle><gtr:id>7B07D93F-916B-480E-A866-C9D72DED2A3C</gtr:id><gtr:outcomeId>qWrTXvBau5U</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Joint database in set-up. Collaboration between Birmingham and Cardiff. Collection of data and outcomes of women with thyroid disorders in pregnancy.</gtr:description><gtr:id>EC886222-E163-4D19-96EF-4086014FA3CD</gtr:id><gtr:impact>No noticeable impacts yet. A number of important outputs expected</gtr:impact><gtr:outcomeId>54639213573176.67201811</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>multi-centre register of pregnant women with thyroid disorders</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Continuation and improvement of database with multiple important outputs.</gtr:description><gtr:id>A45124D0-D4FB-445F-8111-F810FB05BD98</gtr:id><gtr:impact>Multiple high impact factor papers</gtr:impact><gtr:outcomeId>5463926e10bc35.25963882</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Thyroid Clinic Database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Multicentre database collecting baseline data and outcomes of patients treated for thyroid cancer in 6 West Midlands secondary and tertiary care centres</gtr:description><gtr:id>F2A5B56E-4F2B-4BB2-BD10-75C235073EC1</gtr:id><gtr:impact>Database in set-up. No outputs yet. Grant application in progress.</gtr:impact><gtr:outcomeId>546392e46a3526.06150680</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Database of patient with thyroid cancer in West Midlands</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In collaboration with researchers in Cambridge we have analysed a number of samples and identified potential candidate genes</gtr:description><gtr:id>37D9F24E-9A96-4E34-B868-5AE77794C913</gtr:id><gtr:impact>This will help to further unravel the genetic basis of congenital hypothyroidism</gtr:impact><gtr:outcomeId>FgxK4o4w3cW</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Whole exome sequencing to identify novel genes in congenital hypothyroidism</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>In collaboration with Dr Eggo, a world-renowned expert in the field of primary human thyroid cell culture we have improved this methodology and are now in a position to maintain primary human thyrocytes in culture for up to 4 weeks. In addition methodology of performing iodide uptake assays have been optimised.</gtr:description><gtr:id>E7F1E250-BD0D-4855-BB17-8D8A80EFCF24</gtr:id><gtr:impact>We have numerous publications involving primary human thyroid cell culture methodology including PMID: 17297475, 16926250, 15591026, 16394085. The results from our optimised techniques are currently being reported in abstracts to national and international meetings. In addition the results will be reported in manuscripts which will be submitted to high impact factor journals.</gtr:impact><gtr:outcomeId>D92DC6A24C7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Primary human thyroid cell culture</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have established methodology to maintain mouse thyrocytes in primary culture for up to 3 weeks. In addition we have estblished methods of performing iodide uptake assays in these cultures, experiments which are all vital to the characterisation of our transgenic mouse models.</gtr:description><gtr:id>66317F45-CE1F-46D5-AD7F-CD05E450F299</gtr:id><gtr:impact>Results from iodide uptake assays have been included in abstracts submitted to national and international meetings. These data will also be included in forthcoming peer reviewed publications on these results.</gtr:impact><gtr:outcomeId>6AC4CB7E6FB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Primary mouse thyroid cell culture</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have increased our existing cohort of thyroid specimens including normal thyroid samples, goitres and thyroid carcinomas. In addition we have been able to establish a cohort of matched thyroid tissues where normal and tumourous tissue originating from the same thyroid gland have been collected.</gtr:description><gtr:id>6642B6C7-71C9-4B0E-A590-979A2512B697</gtr:id><gtr:impact>We have numerous peer reviewed publications based on our collection of thyroid specimens including: PMID 17297475, 16926250, 16394085, 15886233, 12727994. This expanding resource of samples in invaluable in our ongoing research into the pathogenesis of thyroid tumourigenesis</gtr:impact><gtr:outcomeId>78428ABF702</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human thyroid sample collection</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Collaboration with Dr Patrick Maisonneuve, European Institute of Oncology, Milan to analyse mortality data in patients with thyroid disease.</gtr:description><gtr:id>D9BB3FAD-E7B2-45E7-A130-985637EB3A17</gtr:id><gtr:impact>Presentation of findings presented to national and international audiences. Results are likely to be published in high impact factor journal.</gtr:impact><gtr:outcomeId>Mc9Vv1Bufhn</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Epidemiological analysis of mortality in patients with overt and subclinical hyperthyroidism</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Statisitcal model to predcit weight gain following treatment of hyperthyroidism</gtr:description><gtr:id>14C937BA-9E67-4059-B512-CD451B6D2E64</gtr:id><gtr:impact>This is likely to aid people in the decision making process regarding the most optimal treatment option for hyperthyroidism</gtr:impact><gtr:outcomeId>s1P467ou9mQ</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Model to predict weight gain following treatment for hyperthyroidism</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Use of hospital database for analysis of large patient cohorts</gtr:description><gtr:id>E9A3163F-9459-45A1-B35A-2F6EA74C69CA</gtr:id><gtr:impact>Submission of abstracts to national and international meetings</gtr:impact><gtr:outcomeId>ahxTnZnF4ng</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PICS database</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated a transgenic mouse model with targetted overexpression of PTTG in the thyroid gland. In parallel experiments within our group we have developed a model of thyroid specific overexpression of the PTTG Binding Factor (PBF). In addition we have generated a double trangenic mouse model with targetted overexpression of both PTTG and PBF.</gtr:description><gtr:id>10D7972A-57C5-43C3-9212-FB7A98975D4C</gtr:id><gtr:impact>We are currently in the process of characterising our transgenic mouse models and the results are being reported in abstracts submitted to national and international meetings. These results will in due course be disseminated in manuscripts to be submitted to high impact factor journals.</gtr:impact><gtr:outcomeId>767210C0330</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Generation of Tg-PTTG transgenic mouse model</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0D3B5B3B-5FC0-4888-B812-1FCD2A2CEFB5</gtr:id><gtr:title>Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>92AB045BAF5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CE1BFA4-2E11-49CE-8B8E-EB16FE34CF98</gtr:id><gtr:title>Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.</gtr:title><gtr:parentPublicationTitle>Thyroid : official journal of the American Thyroid Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5cdc2a9da7e3b74f82464476105594"><gtr:id>6a5cdc2a9da7e3b74f82464476105594</gtr:id><gtr:otherNames>Essig GF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1050-7256</gtr:issn><gtr:outcomeId>58c9939cb7f6a1.90514827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43988FE9-725D-4BDD-B218-40959EF074AF</gtr:id><gtr:title>TSHR is the main causative locus in autosomal recessively inherited thyroid dysgenesis.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric endocrinology &amp; metabolism : JPEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290ed8fcf2c9ac0fe9af1f269651106a"><gtr:id>290ed8fcf2c9ac0fe9af1f269651106a</gtr:id><gtr:otherNames>Cangul H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0334-018X</gtr:issn><gtr:outcomeId>pm_15616_26_22876533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D2F7F66-D395-43E0-BE9D-212C92237989</gtr:id><gtr:title>The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/012898a7c14605d6a0c62c3803d6c2c7"><gtr:id>012898a7c14605d6a0c62c3803d6c2c7</gtr:id><gtr:otherNames>Read ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>54635afcbc1407.73697704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AFCE44C-3281-4728-8B83-BD3DB33C2E51</gtr:id><gtr:title>Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e7f7e2253313138ac838b87bf2c4e4a"><gtr:id>7e7f7e2253313138ac838b87bf2c4e4a</gtr:id><gtr:otherNames>Chan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>54634e82823942.75291587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E798F5FC-91F4-4532-BD63-C371F79BDF1B</gtr:id><gtr:title>Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f6b2f868736978ef952b228352f07e6"><gtr:id>8f6b2f868736978ef952b228352f07e6</gtr:id><gtr:otherNames>Edmunds MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>56e0596c751f95.50258432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C7F109-1CC5-4FF1-9654-B8F1EF69C9B3</gtr:id><gtr:title>Iodine status of UK schoolgirls: a cross-sectional survey.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da39959860037a0bffbf29408625c571"><gtr:id>da39959860037a0bffbf29408625c571</gtr:id><gtr:otherNames>Vanderpump MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>trNKj1wamGj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB2E0369-7629-4A3E-96FB-1CB881660907</gtr:id><gtr:title>WOMEN IN CANCER THEMATIC REVIEW: Thyroid-stimulating hormone in thyroid cancer: does it matter?</gtr:title><gtr:parentPublicationTitle>Endocrine-related cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43062141808fa236c26a6d94fb462d26"><gtr:id>43062141808fa236c26a6d94fb462d26</gtr:id><gtr:otherNames>Nieto H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1351-0088</gtr:issn><gtr:outcomeId>58c9939d498319.31468170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72F87B9A-50D4-49AA-9AE6-1D8D14B5BCFB</gtr:id><gtr:title>Thyroid dyshormonogenesis is mainly caused by TPO mutations in consanguineous community.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290ed8fcf2c9ac0fe9af1f269651106a"><gtr:id>290ed8fcf2c9ac0fe9af1f269651106a</gtr:id><gtr:otherNames>Cangul H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>54635d68a65f07.18012961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11C475B6-88E0-46F9-9721-1458130FB7AC</gtr:id><gtr:title>The Endocrinology of Ageing: A Mini-Review.</gtr:title><gtr:parentPublicationTitle>Gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f97a453f085d472294acf37daccdeae"><gtr:id>3f97a453f085d472294acf37daccdeae</gtr:id><gtr:otherNames>Jones CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-324X</gtr:issn><gtr:outcomeId>56e0596c9c2d75.86533438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>979BAA36-891C-418C-A561-21C63265A114</gtr:id><gtr:title>The association between serum TSH concentration and thyroid cancer.</gtr:title><gtr:parentPublicationTitle>Endocrine-related cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1351-0088</gtr:issn><gtr:outcomeId>EB5071EFFA6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F36830DB-2D95-40C4-A505-0DB2203167EE</gtr:id><gtr:title>Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_15616_26_23543662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF76D703-8DCF-40A2-8033-CC0361BC212F</gtr:id><gtr:title>Subclinical thyroid disease: where is the evidence?</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f95a884e25e963608792997746f37ff7"><gtr:id>f95a884e25e963608792997746f37ff7</gtr:id><gtr:otherNames>Franklyn JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>54635a700ddf80.23501619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3465E85B-F073-46AE-A5B7-D394ADAE5ACC</gtr:id><gtr:title>Thyrotoxicosis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f95a884e25e963608792997746f37ff7"><gtr:id>f95a884e25e963608792997746f37ff7</gtr:id><gtr:otherNames>Franklyn JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_15616_26_22394559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54E9B9EF-F011-4441-B37B-EB80DC29CDE2</gtr:id><gtr:title>Costs and benefits of iodine supplementation for pregnant women in a mildly to moderately iodine-deficient population: a modelling analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84bc009f26815e77f7dec23d47a43394"><gtr:id>84bc009f26815e77f7dec23d47a43394</gtr:id><gtr:otherNames>Monahan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>56e05841945358.96253932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1294E098-D3EB-4BCB-984F-6ECF4F52BFAB</gtr:id><gtr:title>Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/012898a7c14605d6a0c62c3803d6c2c7"><gtr:id>012898a7c14605d6a0c62c3803d6c2c7</gtr:id><gtr:otherNames>Read ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>5aa6aac2470db8.21962899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF254438-5E35-4291-A132-AA9A95C38601</gtr:id><gtr:title>A truncating TPO mutation (Y55X) in patients with hypothyroidism and total iodide organification defect.</gtr:title><gtr:parentPublicationTitle>Endocrine research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290ed8fcf2c9ac0fe9af1f269651106a"><gtr:id>290ed8fcf2c9ac0fe9af1f269651106a</gtr:id><gtr:otherNames>Cangul H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0743-5800</gtr:issn><gtr:outcomeId>54634df4e77f69.50810801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14A1B40D-9C91-4A87-9E12-885F285F2EAB</gtr:id><gtr:title>The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.</gtr:title><gtr:parentPublicationTitle>Molecular carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/012898a7c14605d6a0c62c3803d6c2c7"><gtr:id>012898a7c14605d6a0c62c3803d6c2c7</gtr:id><gtr:otherNames>Read ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0899-1987</gtr:issn><gtr:outcomeId>56e0591e869e60.50527377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FAE904D-A5B4-481A-8043-E4634074BB42</gtr:id><gtr:title>Pituitary tumor transforming gene binding factor: a new gene in breast cancer.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d058ad0575b15ba2c32871d75af1652"><gtr:id>2d058ad0575b15ba2c32871d75af1652</gtr:id><gtr:otherNames>Watkins RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>US9Fab7MMkp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBD0F644-142E-4B99-8186-96A2F7A235CD</gtr:id><gtr:title>Thyroid dysfunction in the elderly.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-5029</gtr:issn><gtr:outcomeId>pm_15616_26_23438834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>428C0B72-D19E-45DB-A6F9-2B0ACE36567D</gtr:id><gtr:title>Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.</gtr:title><gtr:parentPublicationTitle>The American journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9343</gtr:issn><gtr:outcomeId>cw4QdoengVJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C498BD8-B0B2-4F7E-84AA-AF98BAE51E4C</gtr:id><gtr:title>Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF.</gtr:title><gtr:parentPublicationTitle>Endocrine-related cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b8ea17464c4af599e9532944942f1be"><gtr:id>3b8ea17464c4af599e9532944942f1be</gtr:id><gtr:otherNames>Imruetaicharoenchoke W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1351-0088</gtr:issn><gtr:outcomeId>5aa6aac20f5d08.10368218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC0F5EFB-154F-48F1-81A7-4B7864799437</gtr:id><gtr:title>Iodine deficiency and thyroid disorders.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82e2e1772e1c0209869d2bad1343ccc4"><gtr:id>82e2e1772e1c0209869d2bad1343ccc4</gtr:id><gtr:otherNames>Zimmermann MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>56e0591e65c6f2.34954852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC86F3C3-2D29-450F-AF4A-C382A4F67E53</gtr:id><gtr:title>A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/144fa3a7f348029948cb76b50c19ba1c"><gtr:id>144fa3a7f348029948cb76b50c19ba1c</gtr:id><gtr:otherNames>Smith VE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>C2490F7F175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B181809-62A8-4955-8201-7F98235F6410</gtr:id><gtr:title>Who should treat thyroid cancer? A UK surgical perspective.</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc2a5ec38a278217b3bed88e037a7848"><gtr:id>fc2a5ec38a278217b3bed88e037a7848</gtr:id><gtr:otherNames>Sharma N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>54635f67ad9420.19931577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60E4D7B1-71CB-4BE3-860D-50A5969FA6F9</gtr:id><gtr:title>Autoimmune encephalopathy in the context of Graves' disease with ophthalmopathy.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce88725eec3a951b0f9544cbef79dc4"><gtr:id>1ce88725eec3a951b0f9544cbef79dc4</gtr:id><gtr:otherNames>Chortis V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>54635ab53c7140.96985993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5283637B-BFFA-4BC1-A1A7-044D5B9B9D5C</gtr:id><gtr:title>Patient information in Graves' disease and thyroid-associated ophthalmopathy: readability assessment of online resources.</gtr:title><gtr:parentPublicationTitle>Thyroid : official journal of the American Thyroid Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f6b2f868736978ef952b228352f07e6"><gtr:id>8f6b2f868736978ef952b228352f07e6</gtr:id><gtr:otherNames>Edmunds MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1050-7256</gtr:issn><gtr:outcomeId>pm_15616_26_24040878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70128A68-1585-4694-B36C-F6D894EAF852</gtr:id><gtr:title>Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/012898a7c14605d6a0c62c3803d6c2c7"><gtr:id>012898a7c14605d6a0c62c3803d6c2c7</gtr:id><gtr:otherNames>Read ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>VFJmdN4NBAp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6853556B-4705-4080-9846-961A0F22AB7F</gtr:id><gtr:title>Thyroid cancer: finding the malignant thyroid nodule in the haystack.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-5029</gtr:issn><gtr:outcomeId>54635ec835d657.18617623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34339133-9A64-48B8-A5E7-953164FBF258</gtr:id><gtr:title>Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone.</gtr:title><gtr:parentPublicationTitle>Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a5cdc2a9da7e3b74f82464476105594"><gtr:id>6a5cdc2a9da7e3b74f82464476105594</gtr:id><gtr:otherNames>Essig GF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1530-891X</gtr:issn><gtr:outcomeId>pm_15616_26_23757627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1DFAF2A-21E3-4EF9-A74F-146DECD5BD8F</gtr:id><gtr:title>Treatment of Graves' disease with antithyroid drugs: current perspectives.</gtr:title><gtr:parentPublicationTitle>Thyroid : official journal of the American Thyroid Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1050-7256</gtr:issn><gtr:outcomeId>54635fb4675522.44881495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05B5AAEF-FDF2-4A5D-93CF-51F30B9C5765</gtr:id><gtr:title>WOMEN IN CANCER PROFILE: From bedside to bench and back: my journey in thyroid disease.</gtr:title><gtr:parentPublicationTitle>Endocrine-related cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1351-0088</gtr:issn><gtr:outcomeId>58c9939d7beb73.50515776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E67AC194-D3C3-4F49-AE92-4BEA049340BA</gtr:id><gtr:title>PTTG and PBF repress the human sodium iodide symporter.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>A74E9032A85</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AB37CDA-A3DA-4C57-982E-4D7FE77BD47D</gtr:id><gtr:title>The pituitary tumor transforming gene in thyroid cancer.</gtr:title><gtr:parentPublicationTitle>Journal of endocrinological investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/040507b191693ca858d85bb13441f7da"><gtr:id>040507b191693ca858d85bb13441f7da</gtr:id><gtr:otherNames>Lewy GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0391-4097</gtr:issn><gtr:outcomeId>pm_15616_26_22522436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43CC073E-F8E9-4834-95B7-D084E1502D50</gtr:id><gtr:title>Thyroid gland: Revised guidelines for the management of thyroid cancer.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1759-5029</gtr:issn><gtr:outcomeId>54636093017794.90852999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3F6C1D-3262-43A5-8842-C20CBBEA58BB</gtr:id><gtr:title>Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89114f898cbfd5118985408745c4f33"><gtr:id>f89114f898cbfd5118985408745c4f33</gtr:id><gtr:otherNames>Boelaert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>Yf2VMNaHwwK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8474E0-C261-4DD4-9B7A-86CC115C6085</gtr:id><gtr:title>Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d058ad0575b15ba2c32871d75af1652"><gtr:id>2d058ad0575b15ba2c32871d75af1652</gtr:id><gtr:otherNames>Watkins RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>58c9939db1d845.18619445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF107618-7FB0-4358-B4E2-31827993733C</gtr:id><gtr:title>Regulation of pituitary tumor transforming gene (PTTG) expression and phosphorylation in thyroid cells.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/040507b191693ca858d85bb13441f7da"><gtr:id>040507b191693ca858d85bb13441f7da</gtr:id><gtr:otherNames>Lewy GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_15616_26_23867215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C58E1E7-0F9B-40B6-B4DD-6AE7F563FE64</gtr:id><gtr:title>Novel truncating thyroglobulin gene mutations associated with congenital hypothyroidism.</gtr:title><gtr:parentPublicationTitle>Endocrine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290ed8fcf2c9ac0fe9af1f269651106a"><gtr:id>290ed8fcf2c9ac0fe9af1f269651106a</gtr:id><gtr:otherNames>Cangul H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-008X</gtr:issn><gtr:outcomeId>pm_15616_26_23949896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27EE4726-288C-424E-BF95-FF58282C810F</gtr:id><gtr:title>Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e00d46dcd17ba63e1b18da728ecfcc9d"><gtr:id>e00d46dcd17ba63e1b18da728ecfcc9d</gtr:id><gtr:otherNames>Okosieme O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>56e0591e410e54.38747887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1392AEA-0640-4F2D-92DF-E4F6E8985F05</gtr:id><gtr:title>PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/144fa3a7f348029948cb76b50c19ba1c"><gtr:id>144fa3a7f348029948cb76b50c19ba1c</gtr:id><gtr:otherNames>Smith VE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_15616_26_22535767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B072F1A9-4C42-4CC3-A28C-5F15ADAC44D5</gtr:id><gtr:title>Separase, securin and Rad21 in neural cell growth.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fe10b2a843d1515741221d37fd9af4"><gtr:id>40fe10b2a843d1515741221d37fd9af4</gtr:id><gtr:otherNames>Pemberton HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn><gtr:outcomeId>D326D0263E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F005FF32-66CE-4B4E-AF13-1C010E625D46</gtr:id><gtr:title>Guidelines for the management of thyroid cancer.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb44723b4b9da181ab2eeaaf7e483c77"><gtr:id>cb44723b4b9da181ab2eeaaf7e483c77</gtr:id><gtr:otherNames>Perros P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>54635a2d44e427.30391304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66247250-7542-4D2B-AF48-298A00F24B69</gtr:id><gtr:title>Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aba2c4531fc83e55b7481f47cab9c89e"><gtr:id>aba2c4531fc83e55b7481f47cab9c89e</gtr:id><gtr:otherNames>Mehanna H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5463597d594790.99152917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5851FB8B-DCD6-49A1-81E2-8053CD3AC741</gtr:id><gtr:title>Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/144fa3a7f348029948cb76b50c19ba1c"><gtr:id>144fa3a7f348029948cb76b50c19ba1c</gtr:id><gtr:otherNames>Smith VE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_15616_26_23678037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>374F52BB-0FB2-4C0E-9CBD-D009AFFB8379</gtr:id><gtr:title>Management of subclinical hypothyroidism in pregnancy: are we too simplistic?</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673aed6e7e2510fa463f2a5f3b22abcd"><gtr:id>673aed6e7e2510fa463f2a5f3b22abcd</gtr:id><gtr:otherNames>Brabant G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>56e0596c4a37d6.00252398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>002EE4AC-8DA8-43D1-A288-B193D2DC93C8</gtr:id><gtr:title>One Base Deletion (c.2422delT) in the TPO Gene Causes Severe Congenital Hypothyroidism.</gtr:title><gtr:parentPublicationTitle>Journal of clinical research in pediatric endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9065691ec6e08ab7eac3db1961969630"><gtr:id>9065691ec6e08ab7eac3db1961969630</gtr:id><gtr:otherNames>Cang?l H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54634e3d0821b7.41659989</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601811</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>